Iovance Biotherapeutics Shares Up On News Of Director Buying

Iovance Biotherapeutics, Inc. (IOVA) shares are gaining more than 12 percent on Monday morning trade on reports that its independent director Wayne Rothbaum bought 28 percent more shares at an average price of $5.

Related Keywords

Wayne Rothbaum , Iovance Biotherapeutics Inc , , Stock Alert , Nova , Iovance Biotherapeutics ,